Finally, a panel of 17 genes recurrently mutated in myeloid neoplasms were studied in the STAT3-mutated MDS-LGLL group, finding a relevant frequency of somatic NRAS variants in about 50% of the cases [82]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.